Revenue | 12/31/2017 | 12/31/2016 | 12/31/2015 |
Total Revenue | - | - | - |
Cost of Revenue | - | - | - |
Gross Profit | - | - | - |
Operating Expenses |
Research Development | 30,255.892 | 20,439.994 | 18,533.363 |
Selling General and Administrative | 10,914.269 | 9,750.702 | 7,576.256 |
Non Recurring | - | - | - |
Others | - | - | - |
Total Operating Expenses | - | - | - |
Operating Income or Loss | -41,170.161 | -30,190.696 | -26,109.619 |
Income from Continuing Operations |
Total Other Income/Expenses Net | 884.946 | 175.058 | 81.057 |
Earnings Before Interest and Taxes | -40,285.215 | -30,015.638 | -26,028.562 |
Interest Expense | 614.264 | 1,029.734 | 1,053.07 |
Income Before Tax | -40,899.479 | -31,045.372 | -27,081.632 |
Income Tax Expense | -9,376.272 | - | - |
Minority Interest | - | - | - |
Net Income From Continuing Ops | -31,523.207 | -31,045.372 | -27,081.632 |
Non-recurring Events |
Discontinued Operations | - | - | - |
Extraordinary Items | - | - | - |
Effect Of Accounting Changes | - | - | - |
Other Items | - | - | - |
Net Income |
Net Income | -31,523.207 | -31,045.372 | -27,081.632 |
Preferred Stock And Other Adjustments | - | - | - |
Net Income Applicable To Common Shares | -31,523.207 | -31,045.372 | -27,081.632 |